Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-13

Clinical Trial Update: Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing flibanserin alone versus flibanserin with sex therapy in hypoactive sexual desire disorder; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flibanserin (Flibanserin)

Snippet

Sponsor: San Diego Sexual Medicine | Conditions: Hypoactive Sexual Desire Disorder | Phase 4 | Status: TERMINATED